MENU
IHE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

IHE stock forecast, quote, news & analysis

The investment seeks to track the investment results of the Dow Jones U... Show more

Category: #Health
IHE
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for IHE with price predictions
Sep 28, 2026

IHE in +0.83% Uptrend, growing for three consecutive days on September 28, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IHE advanced for three days, in 291 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on IHE as a result. In 65 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for IHE just turned positive on September 28, 2026. Looking at past instances where IHE's MACD turned positive, the stock continued to rise in 43 of 52 cases over the following month. The odds of a continued upward trend are 83%.

IHE moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for IHE crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for IHE entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares U.S. Pharmaceuticals ETF (IHE) ETF is 57.79B. The market cap for tickers in the group ranges from 312.09M to 1.05T. LLY holds the highest valuation in this group at 1.05T. The lowest valued company is EYPT at 312.09M.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Pharmaceuticals ETF (IHE) ETF was 14%. For the same ETF, the average monthly price growth was 21%, and the average quarterly price growth was 170%. MAZE experienced the highest price growth at 20%, while OCUL experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Pharmaceuticals ETF (IHE) ETF was 30%. For the same stocks of the ETF, the average monthly volume growth was 38% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 58
Price Growth Rating: 50
SMR Rating: 73
Profit Risk Rating: 67
Seasonality Score: -15 (-100 ... +100)
View a ticker or compare two or three
IHE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
IHE in +0.83% Uptrend, growing for three consecutive days on September 28, 2026